体外循环术后低钾血症370例的护理

1临床资料我院1996-01/2004-12体外循环下行心内直视手术370例,其中先心病240例,冠状动脉搭桥术55例,风心病瓣膜置换术75例,年龄1.5～74.0岁.     

肌腱结嵌压固定法重建前交叉韧带生物力学实验研究

目的探讨绳肌腱结嵌压固定法重建前交叉韧带(ACL)影响初始固定效果的相关因素及对策。方法采用猪膝关节模拟重建ACL不同术式,即绳肌腱结股骨隧道嵌压固定和胫骨端肌腱编织缝合骨桥打结固定法,与骨-髌腱-骨两端界面螺钉固定法,比较其生物力学初始固定最大拔出载荷、抗拉刚度和位移等生物力学指标。结果最大抗拉载荷肌腱结组与正常ACL组接近,无显著性差异;肌腱结组大于骨-髌腱-骨界面螺钉固定组。抗拉载荷在100N和400N时的位移两组无显著性差异。胫骨端肌腱编织缝合骨桥上打结固定组最大抗拉载荷大于BPTB界面螺钉固定组和肌腱编织缝合后界面螺钉固定组。抗拉刚度正常ACL组>骨-髌腱-骨组>绳肌腱结组。最大位移正常ACL<髌腱骨组<肌腱结组。结论绳肌腱结嵌压固定法抗拉强度和刚度完全可以满足重建后ACL的生理需求;术中克服位移因素,是有效防止ACL重建术后松弛的关键。     

两种剂量奥曲肽治疗食管及胃曲张静脉出血效果比较

①目的　比较两种剂量奥曲肽治疗食管、胃曲张静脉出血的临床效果。②方法　将 88例食管、胃曲张静脉出血病人随机分为奥曲肽 5 0 μg/h和 2 5 μg/h剂量组 ,观察平均止血时间、止血率、再出血率和不良反应。 ③结果　 5 0 μg/h组平均止血时间明显短于 2 5 μg/h组 (t=2 .2 4 ,P <0 .0 5 ) ,总止血率明显高于 2 5 μg/h组 (χ2 =5 .36 0 ,P <0 .0 5 ) ,再出血率较 2 5 μg/h组低 (χ2 =7.990 ,P <0 .0 5 )。两组均有 1例病人出现恶心。④结论　奥曲肽 5 0 μg/h剂量治疗食管、胃曲张静脉出血的效果优于 2 5 μg/h剂量     

丙种球蛋白治疗危重早产儿临床分析

目的 为评估IVIG治疗危重早产儿的临床疗效。方法 将危重早产儿116例采取随机分为治疗组和对照组，对照组给常规综合治疗，治疗组在常规综合治疗措施上，加用IVIG静脉滴注，比较治疗组与对照组患儿病情平稳率及死亡率。结果 IVIG治疗危重早产儿病情平稳率第5天达75．8％第10天达93．3％，而对照组分别为50％和70．4％；病死率治疗组为6．4％，对照组为11．1％，均优于常规对照组。结论 危重早产儿用IVIG治疗疗效较满意，值得推广。     

MMP-2、TIMP-2在内毒素诱导性葡萄膜炎中的表达

目的　探讨基质金属蛋白酶 2 (MMP 2 )及其组织型抑制剂 (TIMP 2 )在内毒素诱导性葡萄膜炎 (EIU)模型中的表达及意义。方法　 2 0 0 μg伤寒杆菌内毒素注射于SD大鼠双后足垫 ,建立EIU模型。用免疫组织化学方法检测MMP 2、TIMP 2在内毒素注射后不同时间点 (0、 6、 12、 18、 2 4、 4 8、 72、 96h和 7d)的表达。结果　内毒素注射后 6h开始出现炎症 ,于 2 4h炎症达到高峰 ,以后逐渐减轻 ,7d时基本消退。虹膜、睫状体的上皮细胞和渗出的炎性细胞表达MMP 2和TIMP 2。MMP 2在 6h表达开始增高 ,18～ 2 4h达高峰 ,以后逐渐下降。TIMP 2于 12h出现表达 ,4 8h达高峰 ,以后逐渐下降。TIMP 2和MMP 2平均吸光度值的比值与炎症程度呈负相关。结论　MMP 2是与炎症反应相关的调节因子 ,其过量表达参与葡萄膜炎的发病。减低MMP 2的活性或降低MMP 2 /TIMP 2的比值可能为治疗葡萄膜炎的新思路。     

女性生殖道不同部位检测支原体的序贯试验分析

目的探讨解脲脲原体和人型支原体在女性生殖道的主要寄生部位.方法采用载量一致的标准无菌棉拭子分别于女性阴道穹窿和宫颈口采样,用法国生物梅里埃ID试剂进行解脲脲原体和人型支原体的培养鉴定及半定量计数,按照双向质反应开放型序贯试验设计,对检测结果进行比较分析.结果阴道穹窿部位标本中两种支原体的总阳性数和≥10^4ccu/ml半定量阳性数均高于宫颈口标本.结论对女性进行生殖道支原体感染的检测时应采集阴道穹窿标本,以提高检出率.     

雌激素及其受体对心血管系统保护作用实验研究进展

雌激素对心血管系统具有重要的保护作用。雌激素及其受体主要通过调节血管舒张功能、抑制血管平滑肌细胞增殖和迁移以及影响肾素 -血管紧张素等介导这一保护作用。但临床上雌激素替代治疗尚未得到肯定 ,需进一步研究     

Immunohistochemical characterization of the 'intimal proliferation' phenomenon in Sneddon's syndrome and essential thrombocythaemia

Cellular changes were immunocytochemically characterized in skin vessels of five patients with idiopathic generalized racemose livedo (Sneddon's syndrome), and one patient with localized racemose livedo associated with essential thrombocythaemia. Antibodies against α-smooth muscle-actin, tropomyosin, desmin, vimentin, factor VIII-related antigen, human endothelial cells (CD31), human macrophages (CD68), and HLA-DR positive cells (CR3/43) were used. Conventional light microscopy showed, in all cases, intimal thickening of ascending arteries and arterioles as a result of an accumulation of cells and extracellular hyalinized material. None of the specimens showed infiltration with polymorphonuclear leucocytes or macrophages. The cells in the region of the intimal hyperplasia showed intense positive immunostaining for α-smooth muscle actin and tropomyosin. Staining for the intermediate filament desmin was localized to the resident smooth muscle cells of the media, whereas staining for vimentin was found in all types of cells in both the intima and media. Positive immunostaining for factor VIII-related antigen and CD31 was strictly confined to the endothelial cells lining the narrowed lumina of the vessels. No positive staining with either antibody was observed in totally occluded vessels. Cells in the subintimal space did not show reactivity for CD68 in any of the specimens, but two cases showed solitary cells with positive staining for HLA-DR in this region. There were no differences in staining pattern between Sneddon's syndrome and essential thrombocythaemia with any of the antibodies. Our results support the assumption that the ‘intimal proliferation’ in both diseases is caused by colonization of the subendothelial space with contractile cells of possibel smooth muscle origin. The similarities in histopathology and immunocytochemistry might indicate that in both diseases platelet-derived factors play a causative role.     

Clinical and histological patterns of dermatofibromas of the nail apparatus

True fibromas develop as painless slow-growing nodular tumours. They may appear in any portion of the nail apparatus. The clinical features vary according to their anatomical site. In contrast, the histological features, consisting of a dermal hypocellular reticular nodule with ill-defined demarcation, were similar in all our patients, and factor XIIIa was negative.     

青叶胆Shan酮类化合物的成分研究

目的　分离鉴定青叶胆 Swertia mileensis全草的酮类成分。方法　 95 %乙醇浸提 ,经硅胶柱色谱分离纯化 ,UV,IR,MS,1 H和 1 3CNMR波谱方法确定化学结构。结果　分得 12个酮成分 ,分别为 1-羟基 - 2 ,3,4 ,5 -四甲氧基酮 (1- hydroxy- 2 ,3,4 ,5 - tetramethoxyxanthone, ) ;1-羟基 - 2 ,3,7-三甲氧基酮 (1- hydroxy- 2 ,3,7-trim ethoxyxanthone, ) ;1-羟基 - 2 ,3,5 ,7-四甲氧基酮 (1- hydroxy- 2 ,3,5 ,7- tetram ethoxyxanthone, ) ;1,5 -二羟基 - 2 ,3-二甲氧基酮 (1,5 - dihydroxy- 2 ,3- dimethoxyxanthone, ) ;1,5 -二羟基 - 2 ,3,7-三甲氧基酮 (1,5 - dihy-droxy- 2 ,3,7- trimethoxyxanthone, ) ;1-羟基 - 2 ,3,5 -三甲氧基酮 (1- hydroxy- 2 ,3,5 - trimethoxyxanthone, ) ;1,5 -二羟基 - 2 ,3,4 ,7-四甲氧基酮 (1,5 - dihydroxy- 2 ,3,4 ,7- tetramethoxyxanthone, ) ;1,8-二羟基 - 2 ,3,6 -三甲氧基酮 (1,8- dihydroxy- 2 ,3,6 - trimethoxyxanthone, ) ;1-羟基 - 2 ,3,4 ,7-四甲氧基酮 (1- hydroxy- 2 ,3,4 ,7- te-tramethoxyxanthone, ) ;1,2 ,3,5 -四甲氧基酮 (1,2 ,3,5 - tetromethoxyxanthone, ) ;1-羟基 - 2 ,3,4 ,6 -四甲氧基酮 (1- hydroxyl- 2 ,3,4 ,6